No black box warning on record for Escitalopram Oral Solution

As of the latest FDA labeling reviewed, Escitalopram Oral Solution (ESCITALOPRAM ORAL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Escitalopram Oral Solution medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents, but also when taken alone. If it occurs, discontinue escitalopram and serotonergic agents and initiate supportive treatment ( 4 , 5.2 ) Discontinuation syndrome: When discontinuing escitalopram, reduce dosage gradually whenever possible, and monitor for discontinuation symptoms ( 5.3

No black box warning on record for Escitalopram Oral Solution

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents, but also when taken alone. If it occurs, discontinue escitalopram and serotonergic agents and initiate supportive treatment ( 4 , 5.2 ) Discontinuation syndrome: When discontinuing escitalopram, reduce dosage gradually whenever possible, and monitor for discontinuation symptoms ( 5.3

Escitalopram Oral Solution Black Box Warning

No black box warning on record for Escitalopram Oral Solution

Other warnings & precautions

Escitalopram Oral Solution Black Box Warning

No black box warning on record for Escitalopram Oral Solution

Other warnings & precautions